In the landscape of modern healthcare, a startling revelation emerges: despite the proliferation of pharmaceuticals, few, if any, are designed to cure. Dr. Joel Wallach’s assertion points to a grim reality — our health system prioritizes management over eradication.
With over 250,000 drugs listed in the Physician’s Desk Reference, excluding a handful of antibiotics, none aim to cure.
Instead, they manage symptoms, sustaining a cycle of dependency.
This interdependency between pharmaceuticals and insurance systems reveals a profound issue. The absence of legislation mandating the development of curative drugs underscores a systemic flaw. The focus remains on managing conditions, thereby ensuring continuous consumption of medications.
This approach benefits pharmaceutical companies and insurance entities financially but leaves patients in a perpetual state of treatment without the hope of cure.
Imagine a world where the primary goal is not just to alleviate symptoms but to cure. The lack of such ambition speaks volumes about the priorities set by our healthcare infrastructure. It suggests that economic incentives overshadow the fundamental purpose of medicine — healing.
The current model of healthcare has thus evolved into a ‘sick care’ system, where managing disease takes precedence over curing it.
This paradigm perpetuates a cycle of treatment that benefits industries economically but often at the cost of true patient wellness.
Let us reconsider where we have gone wrong, because it is high time to reboot our Medical Care system from the base to the top.
Yours,
Dr Churchill
PS:
This is a clarion call.
It’s a call to rethink and reshape our approach, placing genuine health and cures at the forefront of medical innovation, and that is where Advance Life Science comes to be useful.
